David C. Heimbrook
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Molecular Biology top 2%
- Melanoma and MAPK Pathways
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Protein Kinase Regulation and GTPase Signaling
- DNA Repair Mechanisms
Papers in
- Oncology 37
- Cancer-related Molecular Pathways 19
-
- Ubiquitin and proteasome pathways 8
- PI3K/AKT/mTOR signaling in cancer 8
- Melanoma and MAPK Pathways 8
- Co-authors
- Christian Tovar (10 shared papers)Lyubomir T. Vassilev (4 shared papers)Allen I. Oliff (23 shared papers)Kathryn E. Packman (16 shared papers)Xiaolan Zhao (3 shared papers)Stephen G. Sligar (6 shared papers)Kenneth Daniel Kolinsky (14 shared papers)Brian Higgins (10 shared papers)
- Journals
- Cancer Research (10 papers)Journal of Biological Chemistry (10 papers)Molecular and Cellular Biology (8 papers)Journal of Medicinal Chemistry (5 papers)Molecular Cancer Therapeutics (4 papers)
- Partner nations
- United StatesSwitzerlandNorway
In The Last Decade
David C. Heimbrook
77 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 117
- Oncology 2.5k
- Molecular Biology 3.7k
- Cell Biology 738
- Cancer Research 515
- Toxicology 117
Countries citing papers authored by David C. Heimbrook
This map shows the geographic impact of David C. Heimbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Heimbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Heimbrook more than expected).
Fields of papers citing papers by David C. Heimbrook
This network shows the impact of papers produced by David C. Heimbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Heimbrook. The network helps show where David C. Heimbrook may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Heimbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 653 | |
| 2 | 2006 | 583 | |
| 3 | 2010 | 345 | |
| 4 | Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models. | 2001 | 201 |
| 5 | 2004 | 197 | |
| 6 | 2011 | 194 | |
| 7 | 1982 | 174 | |
| 8 | 1993 | 172 | |
| 9 | 2009 | 168 | |
| 10 | Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. | 1984 | 167 |
| 11 | 2005 | 165 | |
| 12 | 2011 | 150 | |
| 13 | 1987 | 142 | |
| 14 | 1993 | 115 | |
| 15 | 1993 | 105 | |
| 16 | 2006 | 94 | |
| 17 | 2008 | 84 | |
| 18 | 1994 | 77 | |
| 19 | 1990 | 76 | |
| 20 | 2002 | 71 |
About David C. Heimbrook
David C. Heimbrook is a scholar working on Oncology, Molecular Biology, Cell Biology, Genetics and Immunology, having authored 77 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (19 papers), Virus-based gene therapy research (11 papers), Ubiquitin and proteasome pathways (8 papers), Microtubule and mitosis dynamics (8 papers), Cervical Cancer and HPV Research (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Melanoma and MAPK Pathways (8 papers) and Toxin Mechanisms and Immunotoxins (6 papers). The work is most often cited by research in Oncology (2.5k citations), Molecular Biology (3.7k citations), Cell Biology (738 citations), Cancer Research (515 citations) and Toxicology (117 citations). David C. Heimbrook has collaborated with scholars based in United States, Switzerland and Norway. Frequent co-authors include Christian Tovar, Lyubomir T. Vassilev, Allen I. Oliff, Kathryn E. Packman, Xiaolan Zhao, Stephen G. Sligar, Kenneth Daniel Kolinsky, Brian Higgins, Binh Thanh Vu and Dejan Knezevic. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Molecular and Cellular Biology, Journal of Medicinal Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.